Client Profile

Prior to Oxford Molecular’s acquisition by Pharmacopeia, CooperKatz served as the U.S. public relations agency for this UK company that provided enterprise-wide information technology solutions to the life sciences market. 

Oxford’s integrated services included bioinformatics, cheminformatics and computer-aided chemistry / molecular-modeling.

Our multi-tiered public relations program included writing / distributing product press releases; researching, writing and placing bylined articles; organizing a trade press briefing for a key product launch at the American Chemical Society’s national conference; and designing the Drug Discovery Answer Center, a special Web-based service to media covering the industry

Through these efforts, CooperKatz achieved significant editorial coverage for Oxford Molecular, including several highly-technical bylined articles we wrote for such publications as Modern Drug Discovery and Drug Discovery & Development.